Virtu KCG Holdings’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Virtu KCG Holdings’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$309K	Buy	76,964 +48,225	+168%	+$210K	0.01%	1647
2017 Q1	$106K	Sell	28,739 -86,355	-75%	-$271K	﹤0.01%	2668
2016 Q4	$223K	Buy	115,094 +113,100	+5,672%	+$409K	0.01%	2462
2016 Q3	$12K	Sell	1,994 -2,116	-51%	-$13K	﹤0.01%	2964
2016 Q2	$18K	Buy	+4,110	New	+$26.8K	﹤0.01%	2814
2016 Q1	–	Sell	-2,232	Closed	-$66K	–	4111
2015 Q4	$66K	Buy	2,232 +344	+18%	+$10.4K	﹤0.01%	3106
2015 Q3	$60K	Buy	+1,888	New	+$90.3K	﹤0.01%	2965
2015 Q1	–	Sell	-2,128	Closed	-$200K	–	4299
2014 Q4	$200K	Buy	+2,128	New	+$203K	﹤0.01%	2889
2014 Q3	–	Sell	-1,569	Closed	-$141K	–	4395
2014 Q2	$141K	Buy	+1,569	New	+$96.1K	﹤0.01%	3193

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Virtu KCG Holdings's PTX Position: Q2 2017 in Review

Virtu KCG Holdings increased its Pernix Therapeutics Holdings, Inc. (PTX) stake by 168% in Q2 2017, buying an estimated $210K and bringing the position to 76,964 shares worth $309K. The position accounts for 0.01% of the portfolio, ranked #1647.

Virtu KCG Holdings first reported a position in PTX in Q2 2014 and has held it in 9 quarters since. 30 funds tracked by Wall St. Rank hold PTX as of Q2 2017.

Virtu KCG Holdings held 76,964 shares of Pernix Therapeutics Holdings, Inc. worth $309K as of Q2 2017.
Virtu KCG Holdings bought 48,225 Pernix Therapeutics Holdings, Inc. shares in Q2 2017, an estimated $210K.
Pernix Therapeutics Holdings, Inc. made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1647 holding.
Virtu KCG Holdings first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and has held it in 9 quarters since.
30 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.